Huynh, Nam Cong-Nhat
Ling, Rui
Komagamine, Masatsugu
Shi, Tianshu
Tsukasaki, Masayuki
Matsuda, Kotaro
Okamoto, Kazuo
Asano, Tatsuo
Muro, Ryunosuke
Pluemsakunthai, Warunee
Kollias, George
Kaneko, Yuko
Takeuchi, Tsutomu
Tanaka, Sakae
Komatsu, Noriko
Takayanagi, Hiroshi
Funding for this research was provided by:
AMED (JP20ek0410073)
AMED (JP23ek0410108)
AMED (JP19gm1210008, JP223fa627001, JP22ek0410100, JP21gm6310029)
JSPS (21H05046, 21K18254, 22H02844, 20K21515, 21H03104, 22H03195, JPMJFR205Z, 18F18095)
JST (JPMJFR2261)
Joint Usage/Research Program of Medical Research Institute, TMDU
Medical Research Center Initiative for High Depth Omics and Nanken-Kyoten, TMDU
Article History
Received: 23 February 2024
Accepted: 30 June 2024
First Online: 31 July 2024
Declarations
:
: The experiments were approved by the Institutional Review Board at The University of Tokyo.
: Not applicable.
: The Department of Osteoimmunology is an endowment department supported with an unrestricted grant from AYUMI Pharmaceutical Corporation, ELECOM, JCR Pharmaceuticals, Kondo Cotton Spinning, MIKIHOUSE, MITSUI FUDOSAN, Meiji, Noevir, TAKENAKA, TENNENBUTSU IKAGAKU KENKYU ZAIDAN and Yakult.